Lupin launches Tobramycin Inhalation Solution USP in the US

Nikita Singh
/ Categories: Trending, Markets

In a significant development, Lupin launched its generic Tobramycin Inhalation Solution USP in the US markets on Wednesday. 

Lupin's Tobramycin Inhalation Solution USP, 300 mg/5 ml is the generic equivalent of Novartis Pharmaceuticals Corporation's Tobis 300 mg/5 ml. It is used for the management of cystic fibrosis patients with P. aeruginosa and has an annual sales of around USD 99 million in the US.   

In the past one month, the stock has gained over 13 per cent on the bourses. In Wednesday’s trade, the stock hit an intraday high of Rs. 880.80 per share and an intraday low of Rs. 861 per share on BSE. The stock had touched its 52-week high of Rs. 1,194 per share on June 15, 2017 and its 52-week low of Rs. 723.55 per share on May 15, 2018 on BSE, respectively. 

The stock ended at at Rs. 869.60 per share, up by 1.79 per cent on BSE. Meanwhile, Indian benchmark indices S&P BSE Sensex ended at 35,739.16 level, up by 0.13 per cent and NSE Nifty50 closed at 10,856.70 level, up by 0.13 per cent.  

 

Rate this article:
4.7

Leave a comment

This form collects your name, email, IP address and content so that we can keep track of the comments placed on the website. For more info check our Privacy Policy and Terms Of Use where you will get more info on where, how and why we store your data.
Add comment

DSIJ MINDSHARE

Mkt Commentary31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Mindshare31-Jan, 2023

Knowledge

General27-Jan, 2023

All About Fiscal Policy

All About Fiscal Policy

The United States government directs fiscal policy with the goal of maintaining a healthy economy.

General27-Jan, 2023

Explained: Monetary Policy in India

Explained: Monetary Policy in India

Monetary policy is the activities governed by the central bank that aim to influence the management of the...

General20-Jan, 2023

Cost of Capital Explained!

Cost of Capital Explained!

A business expands by making investments that are expected to increase revenue and profits. It obtains the...
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION